O. A. Salawu1, B. A. Chindo1, A. Y. Tijani1*, I. C. Obidike1, T. A. Salawu2 and A. James Akingbasote1
1Departments of Pharmacology and Toxicology, National Institute for Pharmaceutical Research and Development, P.M.B. 21, Garki, Abuja, Nigeria.
2Departments of Microbiology, Human Virology and Biotechnology National Institute for Pharmaceutical Research and Development (NIPRD), P.M.B 21, Garki, Abuja, Nigeria.
